BJ
AMPH icon

BlackRock Japan’s Amphastar Pharmaceuticals AMPH Stock Holding History

BlackRock Japan’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-622
Closed -$7K – 1320
2014
Q3 		$7K Buy
+622
New +$6.48K ﹤0.01% 1219

Other funds holding AMPH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FCE
Fiera Capital (Europe) Grand Cayman, Cayman Islands $213M AUM 42.35% 1-Year Est. Return

BlackRock Japan's AMPH Position: Q4 2014 in Review

BlackRock Japan sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2014, closing a stake of 622 shares — an estimated $7K sold.

BlackRock Japan first reported a position in AMPH in Q3 2014 and held it in 1 quarter. The position peaked at $7K in Q3 2014. 55 funds tracked by Wall St. Rank hold AMPH as of Q4 2014.

  • BlackRock Japan reported no remaining Amphastar Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • BlackRock Japan sold 622 Amphastar Pharmaceuticals shares in Q4 2014, an estimated $7K.
  • BlackRock Japan first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • BlackRock Japan's Amphastar Pharmaceuticals position peaked at $7K in Q3 2014.
  • 55 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2014.

Based on BlackRock Japan's 13F filing for Q4 2014, filed 9 Feb 2015.